• Home
  1. Home
  2. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
Scientific article
English

Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future

Contributors

Darwich, A S; Ogungbenro, K; Vinks, A A; Powell, J R; Reny, J-L; Marsousi, Niloufar; Daali, Youssef; Fairman, D; Cook, James; Lesko, L J; McCune, J S; Knibbe, Caj; de Wildt, S N; Leeder, J S; Neely, M; Zuppa, A F; Vicini, P; Aarons, L; Johnson, T N; Boiani, J; Rostami-Hodjegan, A

Published in

Clinical Pharmacology and Therapeutics, vol. 101, no. 5, p. 646-656

Publication date

2017

Abstract

Patient groups prone to polypharmacy and special subpopulations are susceptible to suboptimal treatment. Refined dosing in special populations is imperative to improve therapeutic response and/or lowering the risk of toxicity. Model-informed precision dosing (MIPD) may improve treatment outcomes by achieving the optimal dose for an individual patient. There is, however, relatively little published evidence of large-scale utility and impact of MIPD, where it is often implemented as local collaborative efforts between academia and healthcare. This article highlights some successful applications of bringing MIPD to clinical care and proposes strategies for wider integration in healthcare. Considerations are brought up herein that will need addressing to see MIPD become "widespread clinical practice," among those, wider interdisciplinary collaborations and the necessity for further evidence-based efficacy and cost-benefit analysis of MIPD in healthcare. The implications of MIPD on regulatory policies and pharmaceutical development are also discussed as part of the roadmap.

Keywords

  • Cost-Benefit Analysis
  • Delivery of Health Care
  • Integrated
  • Forecasting
  • Humans
  • Models
  • Biological
  • Pharmaceutical Preparations/administration & dosage
  • Precision Medicine/trends

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

DARWICH, A S et al. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future. In: Clinical Pharmacology and Therapeutics, 2017, vol. 101, n° 5, p. 646–656. doi: 10.1002/cpt.659

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0009-9236
614views
0downloads

Technical informations

Creation

18/10/2017 16:02:00

First validation

18/10/2017 16:02:00

Update

15/03/2023 02:17:15

Status update

15/03/2023 02:17:14

Last indexation

31/10/2024 08:26:44
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated